Skip to main content
Log in

Neuroprotective effect of levetiracetam on hypoxic ischemic brain injury in neonatal rats

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Purpose

Hypoxic-ischemic brain injury that occurs in the perinatal period is one of the leading causes of mental retardation, visual and auditory impairment, motor defects, epilepsy, cerebral palsy, and death in neonates. The severity of apoptosis that develops after ischemic hypoxia and reperfusion is an indication of brain injury. Thus, it may be possible to prevent or reduce injury with treatments that can be given before the reperfusion period following hypoxia and ischemia. Levetiracetam is a new-generation antiepileptic drug that has begun to be used in the treatment of epilepsy.

Methods

The present study investigated the effects of levetiracetam on neuronal apoptosis with histopathological and biochemical tests in the early period and behavioral experiments in the late period.

Results

This study showed histopathologically that levetiracetam reduces the number of apoptotic neurons and has a neuroprotective effect in a neonatal rat model of hypoxic-ischemic brain injury in the early period. On the other hand, we demonstrated that levetiracetam dose dependently improves behavioral performance in the late period.

Conclusions

Based on these results, we believe that one mechanism of levetiracetam’s neuroprotective effects is due to increases in glutathione peroxidase and superoxide dismutase enzyme levels. To the best of our knowledge, this study is the first to show the neuroprotective effects of levetiracetam in a neonatal rat model of hypoxic-ischemic brain injury using histopathological, biochemical, and late-period behavioral experiments within the same experimental group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Wilkinson DJ (2009) Cool heads: ethical issues associated with therapeutic hypothermia for newborns. Acta Paediatr 98:217–20

    Article  PubMed  Google Scholar 

  2. Hill A (2006) Hypoxic-ischemic cerebral injury in the newborn. In: Swaiman KF, Ashwal S, Ferriero DM (eds). Pediatric neurology principles & practicer, 4th edn. Philadelphia, p 279–297

  3. Mwaniki MK, Atieno M, Lawn JE, Newton CR (2012) Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet 379:445–52

    Article  PubMed Central  PubMed  Google Scholar 

  4. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ (2005) Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 365:663–70

    Article  PubMed  Google Scholar 

  5. Bonfold E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA (1995) Apoptosis and necrosis: two distinct events, induced respectively by mild and intense insults with N methyl-dospartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci U S A 92:7162–6

    Article  Google Scholar 

  6. Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M, Strohm B, Thoresen M, Whitelaw A, Azzopardi D (2010) Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 340:c363

    Article  PubMed Central  PubMed  Google Scholar 

  7. Patsalos PN (2010) Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther 85:77–85

    Article  Google Scholar 

  8. Verrotti A, D’Adamo E, Parisi P, Chiarelli F, Curatolo P (2010) Levetiracetam in childhood epilepsy. Paediatr Drugs 12:177–86

    Article  PubMed  Google Scholar 

  9. Patsalos PN (2004) Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet 43:707–24

    Article  CAS  PubMed  Google Scholar 

  10. Mazarati AM, Baldwin R, Klitgaard H, Matagne A (2004) Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus. Epilepsy Res 58:167–74

    Article  CAS  PubMed  Google Scholar 

  11. Hanon E, Klitgaard H (2001) Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia. Seizure 10:287–93

    Article  CAS  PubMed  Google Scholar 

  12. Kim JS, Kondratyev A, Tomita Y, Gale K (2007) Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia 48(suppl 5):19–26

    Google Scholar 

  13. Kilicdag H, Daglıoglu K, Erdogan S, Guzel A, Sencar L, Polat S, Zorludemir S (2013) The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury. Early Hum Dev 89:355–60

    Article  CAS  PubMed  Google Scholar 

  14. Khan O, Chang E, Cipriani C, Wright C, Crisp E, Kirmani B (2011) Use of intravenous levetiracetam for management of acute seizures in neonates. Pediatr Neurol 44:265–9

    Article  PubMed  Google Scholar 

  15. Ramantani G, Ikonomidou C, Walter B, Rating D, Dinger J (2011) Levetiracetam: safety and efficacy in neonatal seizures. Eur J Paediatr Neurol 15:1–7

    Article  PubMed  Google Scholar 

  16. Rice JE, Vanucci RC, Brierley JB (1981) The influence of immaturity on hypoxic–ischemic brain damage in the rat. Ann Neurol 9:131–41

    Article  PubMed  Google Scholar 

  17. Ikeda T, Mishima K, Yoshikawa T, Iwasaki K, Fujiwara M, Xia YX, Ikenoue T (2001) Selective and long-term learning impairment following neonatal hypoxic-ischemic brain insult in rats. Behav Brain Res 118:17–25

    Article  CAS  PubMed  Google Scholar 

  18. Johnston MV, Fatemi A, Wilson MA, Northington F (2011) Treatment advances in neonatal neuroprotection and neurointensive care. Lancet Neurol 10:372–82

    Article  PubMed Central  PubMed  Google Scholar 

  19. Shalak L, Perlman JM (2004) Hypoxic-ischemic brain injury in the term infant-current concepts. Early Hum Dev 80:125–41

    Article  PubMed  Google Scholar 

  20. Jensen FE (1997) Perinatal hypoxic-ischemic brain injury: maturation-dependent relation to epilepsy. Ment Retard Dev Disabil Res Rev 3:85–95

    Article  Google Scholar 

  21. Fan X, Kavelaars A, Heijnen CJ, Groenendaal F, van Bel F (2010) Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury. Curr Neuropharmacol 8:324–34

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Glass HC, Ferriero DM (2007) Treatment of hypoxic-ischemic encephalopathy in newborns. Curr. Treat Options Neurol 9:414–23

    Article  Google Scholar 

  23. Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, Dzietko M, Pesditschek S, Mai I, Dikranian K, Olney JW, Ikonomidou C (2002) Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 99:15089–94

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Kabakus N, Ay I, Aysun S, Söylemezoglu F, Ozcan A, Celasun B (2005) Protective effects of valproic acid against hypoxic-ischemic brain injury in neonatal rats. J Child Neurol 20:582–7

    PubMed  Google Scholar 

  25. Liu C, Lin N, Wu B, Qiu Y (2009) Neuroprotective effect of memantine combined with topiramate in hypoxic-ischemic brain injury. Brain Res 1282:173–82

    Article  CAS  PubMed  Google Scholar 

  26. Costa C, Martella G, Picconi B, Prosperetti C, Pisani A, Di Filippo M, Pisani F, Bernardi G, Calabresi P (2006) Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. Stroke 37:1319–26

    Article  CAS  PubMed  Google Scholar 

  27. Papazisis G, Kallaras K, Kaiki-Astara A, Pourzitaki C, Tzachanis D, Dagklis T, Kouvelas D (2008) Neuroprotection by lamotrigine in a rat model of neonatal hypoxic-ischaemic encephalopathy. Int J Neuropsychopharmacol 11:321–9

    Article  CAS  PubMed  Google Scholar 

  28. Noh MR, Kim SK, Sun W, Park SK, Choi HC, Lim JH, Kim IH, Kim HJ, Kim H, Eun BL (2006) Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats. Exp Neurol 201:470–8

    Article  CAS  PubMed  Google Scholar 

  29. Yamada T, Yoneyama Y, Sawa R, Araki T (2003) Effects of maternal oxygen supplementation on fetal oxygenation and lipid peroxidation following a single umbilical cord occlusion in fetal goats. J Nihon Med Sch 70:165–71

    Article  CAS  Google Scholar 

  30. Bågenholm R, Nilsson UA, Kjellmer I (1997) Formation of free radicals in hypoxic ischemic brain damage in the neonatal rat, assessed by an endogenous spin trap and lipid peroxidation. Brain Res 773:132–8

    Article  PubMed  Google Scholar 

  31. Kumar A, Ramakrishna SV, Basu S, Rao GR (2008) Oxidative stress in perinatal asphyxia. Pediatr Neurol 38:181–5

    Article  PubMed  Google Scholar 

  32. Oliveira AA, Almeida JP, Freitas RM, Nascimento VS, Aguiar LM, Júnior HV, Fonseca FN, Viana GS, Sousa FC, Fonteles MM (2007) Effects of levetiracetam in lipid peroxidation level, nitrite-nitrate formation and antioxidant enzymatic activity in mice brain after pilocarpine-induced seizures. Cell Mol Neurobiol 27:395–406

    Article  CAS  PubMed  Google Scholar 

  33. Marini H, Costa C, Passaniti M, Esposito M, Campo GM, Ientile R, Adamo EB, Marini R, Calabresi P, Altavilla D, Minutoli L, Pisani F, Squadrito F (2004) Levetiracetam protects against kainic acid-induced toxicity. Life Sci 74:1253–64

    Article  CAS  PubMed  Google Scholar 

  34. Ramaswamy V, Horton J, Vandermeer B, Buscemi N, Miller S, Yager J (2009) Systematic review of biomarkers of brain injury in term neonatal encephalopathy. Pediatr Neurol 40:215–26

    Article  PubMed  Google Scholar 

  35. Ueda Y, Doi T, Takaki M, Nagatomo K, Nakajima A, Willmore LJ (2009) Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: in vivo evaluation by brain microdialysis combined with ESR spectroscopy. Brain Res 1266:1–7

    Article  CAS  PubMed  Google Scholar 

  36. Katz I, Kim J, Gale K, Kondratyev A (2007) Effects of lamotrigine alone and in combination with MK-801, phenobarbital, or phenytoin on cell death in the neonatal rat brain. J Pharmacol Exp Ther 322:494–500

    Article  CAS  PubMed  Google Scholar 

  37. Fürwentsches A, Bussmann C, Ramantani G, Ebinger F, Philippi H, Pöschl J, Schubert S, Rating D, Bast T (2010) Levetiracetamin the treatment of neonatal seizures: a pilot study. Seizure 19:185–9

    Article  PubMed  Google Scholar 

  38. Abend NS, Gutierrez-Colina AM, Monk HM, Dlugos DJ, Clancy RR (2011) Levetiracetam for treatment of neonatal seizures. J Child Neurol 26:465–70

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Mersin University Scientific and Research Foundation [BAP-TF. DTB (MK) 2011-5(TU)].

Conflict of interest

The authors declare that they have no potential conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mustafa Komur.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Komur, M., Okuyaz, C., Celik, Y. et al. Neuroprotective effect of levetiracetam on hypoxic ischemic brain injury in neonatal rats. Childs Nerv Syst 30, 1001–1009 (2014). https://doi.org/10.1007/s00381-014-2375-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-014-2375-x

Keywords

Navigation